Interactions

Goldenseal's Enzyme Effect: What The Probe-Drug Studies Actually Measured

Eighth of eleven in a blend, no amount printed, and the most consequential name on this panel for anybody taking a prescription. Goldenseal has been measured changing two of the liver enzymes that clear medicines, in people, with probe drugs.

By SodaMelt Team · Last updated September 19, 2026 · 9 min read · Interactions

Why goldenseal rather than the others

Most of the safety discussion around a panel like this one lands on the stimulant botanicals, and reasonably so. But the anthraquinones are a question about how long to take a product. Goldenseal is a question about what else you are already taking, which is a different kind of question and a more urgent one.

The difference is that an interaction does not need the ingredient to be doing anything helpful. A compound that changes how the liver clears a drug changes the amount of that drug in the bloodstream, whether or not it is having any effect of its own.

That is why goldenseal gets a post rather than a bullet point, and why it sits in the printed caution's territory on the safety page as well.

What the enzymes do

The cytochrome P450 family is a set of liver enzymes responsible for metabolising most medicines. Two of them matter most in this story.

CYP3A4 and CYP3A5

This is the workhorse. A very large proportion of prescription drugs are metabolised at least partly here, which is why grapefruit juice has its reputation and why interaction warnings cluster around it. Slowing this enzyme raises the level of a drug in the blood.

CYP2D6

The study that examined it notes that CYP2D6 handles roughly thirty per cent of all medications. It is also an enzyme where people differ genetically, some metabolising quickly and some slowly, which adds a second source of variation on top of any interaction.

From two in vivo studies using midazolam and debrisoquine as probe substrates. Two enzymes affected, two not.

The two negative findings in that table are worth as much as the two positive ones. Goldenseal did not significantly affect CYP1A2 or CYP2E1 in the same study, which is what a careful result looks like: some effects found, others looked for and not found.

What the human studies measured

Gurley's in vivo study gave twelve volunteers twenty-eight days of supplementation and used midazolam and debrisoquine as probe substrates to read enzyme activity directly. Goldenseal was one of four botanicals examined, alongside kava kava, black cohosh and valerian.

Using probe drugs matters. It means the finding is a measurement of enzyme activity in living people rather than an inference from a laboratory dish, which is where a great many herbal interaction claims stop.

A later study by the same group examined CYP2D6-mediated interactions across milk thistle, black cohosh, goldenseal, kava kava, St John's wort and echinacea, and again found goldenseal among the actors.

Mandal's critical review covers the broader picture of goldenseal's constituents, efficacy and toxicological issues, and NCCIH's own fact sheet is the plain-language version for anybody who wants it without the journal formatting.

The dose those studies used

The left column is what produced the measured interaction. The right column is the panel. Neither column tells you what a fraction of a blend does.

The digoxin study states the amount plainly: standardised goldenseal at 3,210 mg daily for fourteen days. That is more than twelve times the entire blend on this panel, and the blend holds ten other ingredients besides.

So the honest position is a two-part one. The amount of goldenseal in one of these capsules is certainly far below the amount that produced a measured interaction. And nobody can say how far below, because the blend sets no figure, and interaction thresholds are not established the way efficacy doses are.

That combination is why the sensible instruction is to mention it rather than to worry about it. A person taking nothing has very little to think about here. A person on a narrow therapeutic index drug has a specific thing to raise with whoever prescribes it.

The digoxin study, and what it did not find

It is worth being accurate about the digoxin work, because it is the study most often cited loosely.

It examined the effect of goldenseal and kava kava supplementation on digoxin pharmacokinetics in humans, at that 3,210 mg daily dose for fourteen days. Digoxin is a sensible choice of subject because its therapeutic window is narrow, so a modest change in blood level matters more than it would for most drugs.

Reporting it as proof that goldenseal is dangerous with every medicine would be overreading it. What the enzyme studies establish is a mechanism with human measurements behind it. What follows from that is a conversation with a prescriber rather than a prediction.

Berberine, and the one other caution

Goldenseal's principal constituent is berberine, and it carries one further caution that is specific rather than general.

The LactMed record notes that berberine can displace bilirubin from serum albumin, and that most sources recommend avoiding neonatal exposure on that basis. That is why goldenseal appears in the same breath as the anthraquinones when a label excludes pregnancy and nursing.

The printed caution on this bottle names pregnant or nursing mothers directly, along with children under 18 and anyone with a known medical condition. On this particular ingredient the reference record and the label agree without any interpretation needed.

What to do with this before buying

1. If you take no prescription medicine, note it and move on. This is not a reason to avoid the product.
2. If you take any prescription medicine, mention goldenseal specifically. Naming the ingredient is far more useful than mentioning a supplement in general terms.
3. Take the bottle or a photograph of the panel. An ingredient list in front of someone beats a description from memory.
4. Say that the amount is inside a blend. That is a relevant fact and it is one a prescriber will want rather than one to be embarrassed about.
5. Space the capsule away from tablets as routine. Sensible around any bulking fibre regardless of the goldenseal question.

Keeping this in proportion

Three things keep this post honest, and leaving any of them out would overstate the case.

• The amount is small. Eighth of eleven inside a quarter-gram blend is not 3,210 mg of standardised extract, and the gap is enormous.
• The findings are about mechanism. Enzyme inhibition measured with probe drugs establishes that goldenseal can do this, not that a capsule will.
• Two of four enzymes were unaffected. The same study that found the interactions looked for two more and did not find them.

What survives all three qualifications is still worth the post. This is the one ingredient on the panel with a named, measured, human interaction mechanism, and it is the one that belongs in a sentence spoken to a prescriber rather than in a paragraph read on a website.

The rest of the safety record for this formula sits on the side effects page, where the anthraquinone question is handled at the length it deserves.

References